Skip to content

Eledon Pharmaceuticals, Inc.

ELDN· NasdaqCore metricsCIK 1404281

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -11.61%
Market cap
$199.32M
84.46M shares
Filings
617
$0.00
Q1 2017
-$3.93M
Q3 2026N/M FY25 yoy
-$21.67M
Q3 2026N/M FY23 yoy
-$4.93M
FY 2016derivedN/M FY16 yoy
-$0.03
Q3 2026N/M FY25 yoy
$6.88M
Q3 2026+11.0% FY25 yoy
$199.32M
—
—
6.5×
—
—

FY2025 figures · derived

Price

$2.36+10.54%+$0.23past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2016
$0.000FY 2012FY 2013FY 2014FY 2015FY 2016
PeriodEndedValueKindSource trail
FY 20162016-12-31$0reported
FY 20152015-12-31$0reported
FY 20142014-12-31$0reported
FY 20132013-12-31$0reported
FY 20122012-12-31$0reported

Pharmaceutical preparations

Eledon Pharmaceuticals, Inc. is the 249th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR